Neogen Corp. (NEOG) stock forecast and price target
Price $11.23 · data as of November 13, 2026
12-month price target
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends May 31, 2027 | $0.33 | +4.2% | $888M |
| Next fiscal year ends May 31, 2028 | $0.45 | +35.0% | $828M |
| Next quarter ends November 30, 2026 | $0.06 | −36.7% | $223M |
| Quarter after ends February 28, 2027 | $0.08 | −7.4% | $214M |
Consensus of the analysts covering Neogen, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 24.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Neogen’s intrinsic value about 83% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Neogen stock price target?
The average 12-month target from 3 analysts is $14.00, 24.7% above the current price of $11.23 Targets range from $14.00 to $14.00.
Is Neogen a buy according to analysts?
The consensus rating is “Buy” (2 strong buy, 1 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Neogen expected to earn?
Analysts expect EPS of $0.33 for the fiscal year ending May 31, 2027 and $0.45 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.